MedPath
TGA Approval

WELIREG belzutifan 40 mg film-coated tablet blister pack (482705)

482705

WELIREG belzutifan 40 mg film-coated tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd

June 25, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

belzutifan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.